Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Non-cash Items: 2020-2024

Historic Non-cash Items for Janux Therapeutics (JANX) over the last 5 years, with Dec 2024 value amounting to $5.4 million.

  • Janux Therapeutics' Non-cash Items rose 18.95% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 18.95%. This contributed to the annual value of $5.4 million for FY2024, which is 3.35% up from last year.
  • As of FY2024, Janux Therapeutics' Non-cash Items stood at $5.4 million, which was up 3.35% from $5.2 million recorded in FY2023.
  • Over the past 5 years, Janux Therapeutics' Non-cash Items peaked at $5.4 million during FY2024, and registered a low of $3.2 million during FY2020.
  • For the 3-year period, Janux Therapeutics' Non-cash Items averaged around $5.2 million, with its median value being $5.2 million (2023).
  • In the last 5 years, Janux Therapeutics' Non-cash Items surged by 57.64% in 2021 and then declined by 2.21% in 2022.
  • Yearly analysis of 5 years shows Janux Therapeutics' Non-cash Items stood at $3.2 million in 2020, then soared by 57.64% to $5.1 million in 2021, then declined by 2.21% to $5.0 million in 2022, then climbed by 5.48% to $5.2 million in 2023, then grew by 3.35% to $5.4 million in 2024.